Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......
Top executives of American pharma companies favour "dialogue" with India and "not confrontation" to address their concerns on key issues like the protection of intellectual property (IP) and......
Indian and US Companies making high quality, low cost generic pharmaceuticals announced the launch of ‘Coalition for Affordable Care’ in Washington on Wednesday. This is to take head on......
The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied. "PhRMA remains......
Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss drugmaker Novartis in denying patent protection to the company’s anti-cancer drug......
The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......